<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Kindred Labs — News</title><description>Announcements, research notes, essays and field notes from Kindred, a research and product company in Lagos, Nigeria.</description><link>https://www.kindredlabs.xyz</link><language>en</language><item><title>Alma Web V2: answers grounded in Nigerian clinical guidelines</title><link>https://www.kindredlabs.xyz/news/alma-web-v2-answers-grounded-in-nigerian-clinical-guidelines</link><guid isPermaLink="true">https://www.kindredlabs.xyz/news/alma-web-v2-answers-grounded-in-nigerian-clinical-guidelines</guid><description>Alma Web V2 answers from a retrieved corpus of Nigerian clinical guidelines and the NAFDAC drug register, cites what it used, and refuses when it finds nothing.</description><pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate><category>Announcements</category></item><item><title>Why we build the rails first</title><link>https://www.kindredlabs.xyz/news/why-we-build-the-rails-first</link><guid isPermaLink="true">https://www.kindredlabs.xyz/news/why-we-build-the-rails-first</guid><description>Why Kindred builds identity, records and reasoning together, and why health is the first place we do it.</description><pubDate>Sun, 23 Aug 2026 00:00:00 GMT</pubDate><category>Essays</category></item></channel></rss>